Shannon Moesaa

Shannon Moesaa currently serves as a member of the Board of Directors for WEST - Women in the Enterprise of Science and Technology since January 2024 and holds the position of VP, Commercial and Healthcare Compliance Counsel at Karuna Therapeutics since November 2022. Shannon's previous roles include Assistant General Counsel at Arena Pharmaceuticals, Inc. from October 2020 to July 2022, and Senior Corporate Counsel at EMD Serono, Inc. from September 2019 to October 2020. Shannon also worked as Senior Corporate Counsel for Rare Diseases at Sanofi Genzyme from August 2016 to September 2019 and as Director of Client Management at Counsel On Call from January 2012 to August 2016. Prior experiences include Associate General Counsel at Novo Nordisk A/S from February 2006 to November 2011, as well as Associate positions at Sonnenschein Nath & Rosenthal and Arnold & Porter in 2004 and 2005, respectively. Educationally, Shannon Moesaa earned a degree from the University of Virginia School of Law between 1999 and 2002 and holds an AB in Anthropology from Harvard University, completed in 1995.